Sign In
Buy CIZN
$9.50
+0 (+0%)
At Close: Jun 03, 2026
Citizens Financial Group, Inc. Declares Dividends on Preferred Stock
04:25pm, Thursday, 01'st May 2025
PROVIDENCE, R.I.--(BUSINESS WIRE)--Citizens Financial Group, Inc. (NYSE: CFG) announced that its board of directors has declared the following dividends on its preferred stock payable on July 7, 2025,
Nuvation Bio to Present at The Citizens Life Sciences Conference
04:05pm, Thursday, 01'st May 2025
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company tackling some of the toughest challenges in cancer treatment, today announced that Philippe Sauvage, Chief Financia
Gain Therapeutics to Participate at The Citizens Life Sciences Conference
07:30am, Thursday, 01'st May 2025
BETHESDA, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development
Prelude Therapeutics to Participate in Citizens Life Sciences Conference
07:30am, Thursday, 01'st May 2025
WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will partic
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
07:05am, Thursday, 01'st May 2025
ALPHARETTA, Ga., May 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the s
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
04:25pm, Wednesday, 30'th Apr 2025
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at The Citizens Life Sciences Conference on Wednesday, May 7t
Quince Therapeutics to Present at Citizens Life Sciences Conference
04:05pm, Wednesday, 30'th Apr 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biolog
Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025
04:05pm, Wednesday, 30'th Apr 2025
AUSTIN, Texas , April 30, 2025 /PRNewswire/ -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unme
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference
04:05pm, Wednesday, 30'th Apr 2025
FOSTER CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio
Senti Bio to Present at the Citizens JMP Life Sciences Conference
09:00am, Wednesday, 30'th Apr 2025
Live video webcast presentation on Thursday, May 8 th at 1:00 PM ET Presentation will highlight the recently announced positive preliminary clinical results of lead program, SENTI-202, in the treatmen
Cidara Therapeutics to Participate in The Citizens Life Sciences Conference
08:00am, Wednesday, 30'th Apr 2025
SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeut
Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
08:00am, Wednesday, 30'th Apr 2025
WEST CHESTER, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for sk
Solid Biosciences to Participate at The Citizens Life Sciences Conference
08:00am, Wednesday, 30'th Apr 2025
CHARLESTOWN, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neur
Citizens Financial Group Elevates Brendan Coughlin to President
07:45am, Wednesday, 30'th Apr 2025
PROVIDENCE, R.I.--(BUSINESS WIRE)--Citizens Financial Group, Inc. (NYSE: CFG) today announced that Brendan Coughlin, currently Vice Chair and Head of Consumer, Private Banking and Wealth, has been pro
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
07:30am, Wednesday, 30'th Apr 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative
